• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊柱脊髓脑膜瘤与临床症状的关系。

Spinal cord compression in relation to clinical symptoms in patients with spinal meningiomas.

机构信息

Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Surgery, Varberg Hospital, Varberg, Sweden.

出版信息

Clin Neurol Neurosurg. 2021 Dec;211:107018. doi: 10.1016/j.clineuro.2021.107018. Epub 2021 Nov 16.

DOI:10.1016/j.clineuro.2021.107018
PMID:34808478
Abstract

OBJECTIVE

Spinal meningiomas are common primary tumors of the spinal canal and the resulting spinal cord compression (SCC) is intrinsically related to symptoms and outcome, but literature concerning this association is limited. We aimed to present data on both degree of SCC and tumor occupancy percentage in relation to neurological symptoms and outcome.

METHODS

Patients ≥ 18 years with a histological diagnosis of spinal canal meningioma treated between 2000 and 2017 were retrospectively evaluated for symptoms and neurological outcome in relation to SCC (i.e. compression of spinal cord at maximal tumor compression compared to maximum area above/below compression) and tumor occupancy percentage (percentage of dural sac area occupied by tumor at maximal tumor compression). Area segmentation of spinal cord, tumor and dural sac (as marker of spinal canal) was performed manually on magnetic resonance imaging (MRI) scans. The neurological deficit was assessed pre- and postoperatively according to the McCormick score. A logistic regression was made with a training set to identify the cut-off level for motor deficit.

RESULTS

The cohort included 111 patients with a mean age of 62.5 years and 77.5% were female. The dominating symptoms preoperatively were sensory disturbance (91.0%), motor deficit (80.2%) and gait disturbance (67.6%). Postoperatively 53.2% of patients, also in some of those with severe deficit and high tumor occupancy, improved their neurological deficit and 43.2% were unchanged. Patients with intradural meningioma and assessable MRI scans were included to evaluate SCC (n = 83). The mean extent of SCC was 50.6%. Exploration of tumor occupancy percentage identified a cut-off at 65% tumor occupancy to best discriminate between patients with or without motor deficit.

CONCLUSION

Patients with an intradural tumor occupancy percentage of > 65% are more likely to have a preoperative symptom and deficit, validating previous findings. Therefore, we suggest that even in asymptomatic, otherwise fit, patients with tumor occupancy approaching 65% should be considered for surgery since there is a high risk of developing deficit with even minimal growth. Concerning recovery, patients with tumor both high tumor occupancy and significantly impaired function tended to improve their functional level postoperatively.

摘要

目的

脊髓脊膜瘤是椎管内常见的原发性肿瘤,由此导致的脊髓压迫(SCC)与症状和预后密切相关,但相关文献有限。我们旨在提供与神经症状和预后相关的 SCC 严重程度和肿瘤占位百分比的数据。

方法

回顾性分析 2000 年至 2017 年间接受治疗的、组织学诊断为椎管脊膜瘤的≥18 岁患者的症状和神经预后,分析 SCC(即最大肿瘤压迫时脊髓受压程度与最大受压上下脊髓面积之比)和肿瘤占位百分比(最大肿瘤压迫时肿瘤占硬脑膜囊面积的百分比)与神经症状和预后的关系。在磁共振成像(MRI)扫描上手动对脊髓、肿瘤和硬脑膜囊(作为椎管标志物)进行区域分割。术前和术后根据 McCormick 评分评估神经缺损情况。使用训练集进行逻辑回归,以确定运动缺损的截断水平。

结果

该队列包括 111 名平均年龄为 62.5 岁的患者,其中 77.5%为女性。术前主要症状为感觉障碍(91.0%)、运动障碍(80.2%)和步态障碍(67.6%)。术后,53.2%的患者,包括一些有严重缺损和高肿瘤占位的患者,神经功能缺损得到改善,43.2%的患者无变化。纳入了可评估 MRI 扫描的硬脊膜内脊膜瘤患者以评估 SCC(n=83)。SCC 的平均程度为 50.6%。对肿瘤占位百分比的研究确定了 65%肿瘤占位的截断值,以最佳区分有无运动障碍的患者。

结论

硬脊膜内肿瘤占位百分比>65%的患者更有可能出现术前症状和缺损,这验证了先前的发现。因此,我们建议,即使在无症状、身体状况良好的患者中,当肿瘤占位接近 65%时,也应考虑手术,因为即使肿瘤有极小的生长,也有发生缺损的高风险。关于恢复,肿瘤占位百分比高且功能严重受损的患者术后倾向于改善其功能水平。

相似文献

1
Spinal cord compression in relation to clinical symptoms in patients with spinal meningiomas.脊柱脊髓脑膜瘤与临床症状的关系。
Clin Neurol Neurosurg. 2021 Dec;211:107018. doi: 10.1016/j.clineuro.2021.107018. Epub 2021 Nov 16.
2
Spinal meningioma: relationship between degree of cord compression and outcome.脊髓脑膜瘤:脊髓受压程度与预后的关系。
Br J Neurosurg. 2017 Apr;31(2):209-211. doi: 10.1080/02688697.2016.1206180. Epub 2016 Jul 8.
3
Risk factors for preoperative neurological impairment in patients with spinal meningioma: A retrospective multicenter study.脊柱脑膜瘤患者术前神经功能障碍的危险因素:一项回顾性多中心研究。
J Clin Neurosci. 2024 Aug;126:187-193. doi: 10.1016/j.jocn.2024.06.021. Epub 2024 Jun 27.
4
Craniocervical junction intradural extramedullary meningioma with cord compression.颅颈交界区硬脊膜外髓内脑膜瘤伴脊髓压迫。
BMJ Case Rep. 2023 Jul 12;16(7):e255544. doi: 10.1136/bcr-2023-255544.
5
Ossification in an extra-intradural spinal meningioma-pathologic and surgical vistas.骨化在硬脊膜外脊髓膜瘤中的表现——病理与手术视角。
Spine J. 2013 Dec;13(12):e21-6. doi: 10.1016/j.spinee.2013.06.102. Epub 2013 Sep 14.
6
Impact of spinal cord compression from intradural and epidural spinal tumors on perioperative symptoms-implications for surgical decision making.硬膜内和硬膜外脊髓肿瘤导致的脊髓压迫对围手术期症状的影响——对手术决策的启示
Neurosurg Rev. 2017 Jul;40(3):377-387. doi: 10.1007/s10143-016-0790-z. Epub 2016 Oct 7.
7
Treatable extramedullary cord compression. Meningioma as a cause of the Brown-Séquard syndrome.可治疗的脊髓外压迫。脑膜瘤作为布朗-塞卡尔综合征的病因。
Spine (Phila Pa 1976). 1980 Jan-Feb;5(1):19-22.
8
Relationship between the anatomic and dermatomal levels of spinal cord tumors in the thoracic region.胸段脊髓肿瘤的解剖学水平与皮节水平之间的关系。
J Spinal Disord. 1995 Apr;8(2):93-102.
9
Unusual appearance of an en plaque meningioma of the cervical spinal canal. A case report and literature review.颈椎管内斑块状脑膜瘤的异常表现。病例报告及文献综述
Spine (Phila Pa 1976). 2001 Mar 1;26(5):E87-9. doi: 10.1097/00007632-200103010-00004.
10
Ossified extradural en-plaque meningioma of the cervical spine.颈椎骨化性硬膜内板脑膜瘤
J Clin Neurosci. 2018 Apr;50:124-126. doi: 10.1016/j.jocn.2018.01.058. Epub 2018 Feb 14.

引用本文的文献

1
Clinical, molecular, and genetic features of spinal meningiomas.脊髓脑膜瘤的临床、分子和遗传特征
Neurooncol Adv. 2024 Aug 31;6(Suppl 3):iii73-iii82. doi: 10.1093/noajnl/vdae123. eCollection 2024 Oct.
2
Does the presence or absence of preoperative lower extremity neurologic symptoms influence postoperative clinical outcome in patients with cervical intradural extramedullary tumors?: a single-center retrospective comparative study.术前下肢神经症状的有无是否会影响颈髓外硬膜内肿瘤患者的术后临床结果?一项单中心回顾性对照研究。
Spinal Cord. 2025 Jan;63(1):9-15. doi: 10.1038/s41393-024-01042-0. Epub 2024 Oct 9.
3
Functional outcome after introduction of hemilaminectomy in management of spinal schwannomas and meningiomas.
半椎板切除术应用于脊髓神经鞘瘤和脊膜瘤治疗后的功能转归
Heliyon. 2024 Jul 26;10(15):e35346. doi: 10.1016/j.heliyon.2024.e35346. eCollection 2024 Aug 15.
4
Does the degree of preoperative gait disturbance remain after tumor resection in patients with intradural extramedullary spinal cord tumors?在硬脊膜外脊髓肿瘤患者中,肿瘤切除术后术前步态障碍的严重程度是否仍然存在?
Spinal Cord. 2023 Dec;61(12):637-643. doi: 10.1038/s41393-023-00931-0. Epub 2023 Aug 28.
5
Spinal meningiomas, from biology to management - A literature review.脊髓脑膜瘤:从生物学特性到治疗——文献综述
Front Oncol. 2023 Jan 13;12:1084404. doi: 10.3389/fonc.2022.1084404. eCollection 2022.
6
Current Knowledge on Spinal Meningiomas Epidemiology, Tumor Characteristics and Non-Surgical Treatment Options: A Systematic Review and Pooled Analysis (Part 1).脊髓脑膜瘤的流行病学、肿瘤特征及非手术治疗选择的当前知识:系统评价与汇总分析(第1部分)
Cancers (Basel). 2022 Dec 19;14(24):6251. doi: 10.3390/cancers14246251.
7
Unsuccessful external validation of the MAC-score for predicting increased MIB-1 index in patients with spinal meningiomas.用于预测脊膜瘤患者MIB-1指数升高的MAC评分的外部验证未成功。
Front Oncol. 2022 Nov 29;12:1037495. doi: 10.3389/fonc.2022.1037495. eCollection 2022.
8
Surgical Treatment of Spinal Meningiomas in the Elderly (≥75 Years): Which Factors Affect the Neurological Outcome? An International Multicentric Study of 72 Cases.老年(≥75岁)脊髓膜瘤的外科治疗:哪些因素影响神经功能预后?一项72例的国际多中心研究。
Cancers (Basel). 2022 Sep 30;14(19):4790. doi: 10.3390/cancers14194790.